Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biotronik Rolls Out Biomonitor III Injectable Cardiac Monitor

Executive Summary

The company says Biomonitor III documents suspected arrhythmias or unexplained syncope in patients who have experienced cardiac arrhythmias or who are at risk for cardiac arrhythmias.

You may also be interested in...



Minute Insight: Biotronik Launches Remote Monitor That Can Prevent Heart Failure Hospitalizations

The HeartInsight algorithm combines heart failure parameters into a predictive score and alerts physicians if a patient with an implanted ICD or CRT-D is at higher risk of hospitalization. Biotronik will roll out HeartInsight in Europe in April.

Biotronik Adds Temperature Sensing To Biomonitor IIIm Injectable Cardiac Monitor

The US FDA cleared the Vital Data Sensor, which identifies body temperature increases that can indicate a fever caused by an infection.

Interview: New Biotronik CMO David Hayes Builds Physician Education, Clinical Trial Relationships

In an interview with Medtech Insight, Biotronik president Ryan Walters explained why the former Mayo Clinic cardiologist was the right choice to be the first CMO in the company's history and David Hayes discussed his reasons for taking the job.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT125547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel